CLSA Reiterates Sell (5) Rating on Glenmark Pharmaceuticals Ltd. (GNP:IN)
Tweet
Share
E-mailCLSA analyst Akok Dalal reiterated a Sell (5) rating and INR490.00 price target on Glenmark Pharmaceuticals Ltd. (GNP:IN).
You May Also Be Interested In
- NMDC Ltd (NMDC:IN) PT Raised to INR186 at Credit Suisse
- Acerinox SA (ACX:SM) (ANIOY) PT Raised to EUR13.50 at Jefferies
- Aperam SA (APAM:NA) (APEMY) PT Raised to EUR40 at Jefferies
Create E-mail Alert Related Categories
Intl RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
